Arovella Therapeutics
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
Industry Lists
Public Companies - non WAArovella Therapeutics, formerly SUDA Pharmaceuticals, is a former Perth-based, ASX-listed pharmaceutical company.
Originally focused solely on oro-mucosal drug delivery, the company changed its name to Arovella following the acquisition of the iNKT cell therapy platform for cancer treatment.
Its two focus areas are oncology and conditions that impact the central nervous system.
Contact Details
Level 1, Unit 12, 55 Howe Street, OSBORNE PARK WA 6017
08 6142 5555
Lists and Charts
Share price
Closing price for the last 90 trading days
Powered by Morningstar ®
Total Shareholder Return as at 29/11/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 126th | Arovella Therapeutics | 107% | 24% |
1740 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Arovella Therapeutics | $2.0m |
1333 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Company Activity
| NEWS: Tagged in Board Moves March 13, 2023 | 13 Mar 2023 |
| NEW ROLE: Tom Duthy, Non-Executive Chair | 13 Mar 2023 |
| ECM DEAL: New deal has been added | 07 Mar 2023 |
| NEW ROLE: Nicole van der Weerden, Chief Operating Officer | 04 Jan 2023 |
| ADDED: Added to Public Companies - non WA list | 26 Oct 2022 |
| NEWS: Tagged in Arovella to shut Perth R&D facility | 26 Oct 2022 |
| NEWS: Tagged in Board Moves July 1, 2022 | 01 Jul 2022 |
| NEW ROLE: Gary Phillips, Non-Executive Director | 01 Jul 2022 |
| NEWS: Tagged in Board Moves June 7, 2022 | 07 Jun 2022 |
